The Online Investor
Natus Medical Inc. (BABY)

Natus Medical is a provider of neurology, newborn care, and hearing and balance assessment healthcare products and services. Co. has three business units: Neuro, which includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care and neurosurgery; Newborn Care, which includes products and services for newborn care including hearing screening, brain injury, retinopathy of prematurity vision screening, thermoregulation, jaundice management, and various disposable newborn care supplies; and Otometrics, which includes products for hearing and diagnostics and hearing aid fitting, including computer-based audiological.
Company Name: 
Natus Medical Inc.
Stock buyback: 
BABY buyback
Website: 
www.natus.com
Sector: 
Medical Instruments & Supplies
Quotes delayed 20 minutes



Hold (2.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Natus Medical Inc. (BABY) Page | The Online Investor Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.